Education
About Us
Working with TipRanks
Follow Us
ProMIS Neurosciences (PMN)
NASDAQ:PMN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | - | - |
| Gross Profit | $ 0.00 | $ -10.44M | $ -21.78M | - | - |
| Operating Income | $ -16.83B | $ -18.90M | $ -23.38M | - | - |
| EBITDA | $ -16.83B | $ -17.81M | $ -29.88M | $ -9.33M | - |
| Net Income | $ 2.78B | $ -17.51M | $ -12.74M | - | - |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.32M | $ 16.75M | $ 8.01M | $ 21.48M | $ 1.11M |
| Total Assets | $ 18.91M | $ 18.04M | $ 9.38M | $ 22.44M | $ 1.38M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 4.94M | $ 0.00 |
| Net Debt | $ -13.29M | $ -16.69M | $ -7.96M | $ -16.49M | $ -1.03M |
| Total Liabilities | $ 2.42M | $ 13.07M | $ 8.68M | $ 15.28M | $ 2.40M |
| Stockholders' Equity | $ 16.49B | $ 4.97M | $ 0.00 | $ 7.16M | $ -1.02M |
| Cash Flow | |||||
| Free Cash Flow | $ -27.18M | $ -14.37M | $ -17.04M | - | - |
| Operating Cash Flow | $ -27.18M | $ -14.37M | $ -17.03M | - | - |
| Investing Cash Flow | - | - | $ -1.98K | $ 94.33K | - |
| Financing Cash Flow | $ 27.88M | $ 23.52M | $ 6.49M | $ 25.20M | $ 3.01M |
ProMIS Neurosciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.